Home›Valproic Acid›Valproic Acid + Asprin And Extended Release Dipyridamole

Does Valproic Acid Interact with Asprin And Extended Release Dipyridamole?

CDI records a moderate classification for Valproic Acid and Asprin And Extended Release Dipyridamole. The stored summary is: Salicylic acid can displace protein-bound valproic acid, leading to increased serum valproic acid levels. The mechanism involves protein binding displacement. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Moderate
Valproic Acid Class
Anti-epileptic Agent
Asprin And Extended Release Dipyridamole Class
Nonsteroidal Anti-inflammatory Drug
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

Protein binding displacement

What To Tell Your Doctor or Pharmacist

If you are taking Valproic Acid and your doctor is considering prescribing Asprin And Extended Release Dipyridamole (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Valproic Acid(Valproic Acid)+💊 Asprin And Extended Release Dipyridamole(Asprin And Extended-Release Dipyridamole)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Anti-epileptic Agent
Drug B class
Nonsteroidal Anti-inflammatory Drug
Source
NLP:asprin and extended-release dipyridamole

What this means in plain English

Salicylic acid can displace protein-bound valproic acid, leading to increased serum valproic acid levels.

About Valproic Acid and Asprin And Extended Release Dipyridamole

Valproic Acid is an Anti-epileptic Agent, while Asprin And Extended Release Dipyridamole is a Nonsteroidal Anti-inflammatory Drug. Valproic Acid additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:asprin and extended-release dipyridamole

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Valproic Acid and Asprin And Extended Release Dipyridamole against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations